Literature DB >> 26531122

Neurocognitive functions and health-related quality of life in glioblastoma patients: a concise review of the literature.

E Bergo1,2, G Lombardi1, I Guglieri2, E Capovilla2, A Pambuku1, V Zagone1.   

Abstract

The maintenance of quality of life in patients with high-grade glioma is an important endpoint during treatment, particularly in those with glioblastoma multiforme, given its dismal prognosis; thus, the primary aims of treatments are to reduce morbidity, restore or preserve neurological functions, and the capacity to perform daily activities. This review aims to summarise what is currently known about neurocognitive outcome and quality of life in patients with high-grade glioma, particularly in glioblastoma patients. We considered all the variables that can influence neurocognitive functions, the perception of quality of life and their role as predictors for treatment outcomes.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  glioma; neurocognitive functions; quality of life

Mesh:

Year:  2015        PMID: 26531122     DOI: 10.1111/ecc.12410

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  12 in total

1.  Perioperative levetiracetam for seizure prophylaxis in seizure-naive brain tumor patients with focus on neurocognitive functioning.

Authors:  Elias Konrath; Franz Marhold; Wolfgang Kindler; Florian Scheichel; Branko Popadic; Katrin Blauensteiner; Bernadette Calabek; Elisabeth Freydl; Michael Weber; Robin Ristl; Katharina Hainz; Camillo Sherif; Stefan Oberndorfer
Journal:  BMC Neurol       Date:  2022-07-08       Impact factor: 2.903

2.  Classical and disease-specific quality indicators in glioma surgery-Development of a quality checklist to improve treatment quality in glioma patients.

Authors:  Christiane Menke; Sebastian Lohmann; Andrea Baehr; Oliver Grauer; Markus Holling; Benjamin Brokinkel; Michael Schwake; Walter Stummer; Stephanie Schipmann
Journal:  Neurooncol Pract       Date:  2021-10-11

Review 3.  Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art.

Authors:  E Bergo; G Lombardi; A Pambuku; A Della Puppa; L Bellu; D D'Avella; V Zagonel
Journal:  Biomed Res Int       Date:  2016-07-14       Impact factor: 3.411

4.  Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.

Authors:  Sophie J M Rijnen; Elke Butterbrod; Geert-Jan M Rutten; Margriet M Sitskoorn; Karin Gehring
Journal:  Neurosurgery       Date:  2020-11-16       Impact factor: 4.654

Review 5.  Palliative Care in High-Grade Glioma: A Review.

Authors:  Rita C Crooms; Nathan E Goldstein; Eli L Diamond; Barbara G Vickrey
Journal:  Brain Sci       Date:  2020-10-13

6.  Glioma-Induced Disruption of Resting-State Functional Connectivity and Amplitude of Low-Frequency Fluctuations in the Salience Network.

Authors:  J Yang; S Gohel; Z Zhang; V Hatzoglou; A I Holodny; B A Vachha
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-31       Impact factor: 3.825

7.  fMRI Retinotopic Mapping in Patients with Brain Tumors and Space-Occupying Brain Lesions in the Area of the Occipital Lobe.

Authors:  Katharina Hense; Tina Plank; Christina Wendl; Frank Dodoo-Schittko; Elisabeth Bumes; Mark W Greenlee; Nils Ole Schmidt; Martin Proescholdt; Katharina Rosengarth
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

8.  Palliative Care Consultation for Hospitalized Patients with Primary and Secondary Brain Tumors at a Single Academic Center.

Authors:  Rita C Crooms; Hung-Mo Lin; Sean Neifert; Stacie G Deiner; Jess W Brallier; Nathan E Goldstein; Jonathan S Gal; Laura P Gelfman
Journal:  J Palliat Med       Date:  2021-06-24       Impact factor: 2.947

9.  Distributed changes of the functional connectome in patients with glioblastoma.

Authors:  Karl-Heinz Nenning; Julia Furtner; Barbara Kiesel; Ernst Schwartz; Thomas Roetzer; Nikolaus Fortelny; Christoph Bock; Anna Grisold; Martha Marko; Fritz Leutmezer; Hesheng Liu; Polina Golland; Sophia Stoecklein; Johannes A Hainfellner; Gregor Kasprian; Daniela Prayer; Christine Marosi; Georg Widhalm; Adelheid Woehrer; Georg Langs
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

10.  Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment.

Authors:  Karine A Al Feghali; James W Randall; Diane D Liu; Jeffrey S Wefel; Paul D Brown; David R Grosshans; Sarah A McAvoy; Maguy A Farhat; Jing Li; Susan L McGovern; Mary F McAleer; Amol J Ghia; Arnold C Paulino; Erik P Sulman; Marta Penas-Prado; Jihong Wang; John de Groot; Amy B Heimberger; Terri S Armstrong; Mark R Gilbert; Anita Mahajan; Nandita Guha-Thakurta; Caroline Chung
Journal:  Neurooncol Adv       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.